Validation of a Proliferation-based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma

PURPOSE: New prognostic markers to guide treatment decisions in early stage non-small cell lung cancer are necessary to improve patient outcomes. In this report, we assess the utility of a pre-defined mRNA expression signature of cell cycle progression genes (CCP score) to define 5-year risk of lung...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wistuba, Ignacio I., Behrens, Carmen, Lombardi, Francesca, Wagner, Susanne, Fujimoto, Junya, Raso, M. Gabriela, Spaggiari, Lorenzo, Galetta, Domenico, Riley, Robyn, Hughes, Elisha, Reid, Julia, Sangale, Zaina, Swisher, Steven G., Kalhor, Neda, Moran, Cesar A., Gutin, Alexander, Lanchbury, Jerry. S., Barberis, Massimo, Kim, Edward S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3834029/
https://ncbi.nlm.nih.gov/pubmed/24048333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0596
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados